Full Text (PDF)
Case Report

Reperfusion Induced Fatal Hemorrhagic Myocardial Infarction: A Case Report

Abhishek Yadav, Gokul G, Abdul Raoof MP, Amar Ranjan, Manivel S

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


Journal of Forensic Chemistry and Toxicology 9(1):p 53-57, January – June 2023. | DOI: http://dx.doi.org/10.21088/jfct.2454.9363.9123.4

How Cite This Article:

Gokul G, Raoof MP, Yadav A, Gupta SK, Chandran VA, Abilash S. Reperfusion induced fatal hemorrhagic myocardial infarction: a case report. J Forensic Chem Toxicol. 2023;9(1):53–57.

Timeline

Received : October 11, 2022         Accepted : November 13, 2022          Published : June 30, 2023

Abstract

Sudden death due to coronary artery disease is the leading cause of death globally. Occlusive coronary artery disease results in ischemia of myocardial tissue and subsequent infarction. Various treatment modalities like blood thinners, percutaneous coronary intervention (PCI) etc are being employed in the treatment of acute myocardial infarction (MI). However, these modalities have their own limitations. In this case, reperfusion therapy resulted in hemorrhagic myocardial infarction (HMI) with a fatal outcome. An adult male with history of sudden collapse was brought to the emergency department, where he was declared as brought dead. He underwent reperfusion therapy and was on blood thinners, 4 days before the incident. On autopsy, we could find the features of hemorrhagic myocardial infarction grossly and the same was confirmed histopathologically. Though reperfusion injuries are commonly documented, deaths due to hemorrhagic myocardial Infarction, which is one of the rare complications of reperfusion therapy, are rarely reported. The important role of forensic pathologists in this case is to identify the rare causes, which led the patient to death during management of occlusive coronary artery disease.


References

  • 1.   Ambrosio G, Tritto I. Myocardial reperfusion injury. Eur Hear Journal, Suppl. 2002;4(B):1121–35.
  • 2.   Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi SKBM, AlKatheeri R, Alblooshi FMK, Almatrooshi MEAH, Alzaabi MEH, Al Darmaki RS, Lootah SNAH. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020 Jul 23;12(7):e9349.
  • 3.   Piper HM, García-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 1998 May;38(2):291-300.
  • 4.   Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007 Sep 13;357(11):1121-35.
  • 5.   Jayaraj JC , Davatyan K , Subramanian, S, Priya, J. Epidemiology of Myocardial Infarction. In: Pamukçu, B, editor. Myocardial Infarction [Internet]. London: IntechOpen; 2018 [cited 2022 Jul 01]. Available from: https://www.intechopen. com/chapt.
  • 6.   Robbins & Cotran Pathologic Basis of Disease, 10e: South Asia Edition, 2 Vol SET - 10th Edition [Internet]. [cited 2022 Jul 12]. Available from: https://www.elsevier.com/books/robbins-&- cotran-pathologic-basis-of-disease-10e-south-asiaedition-2-vol-set/978-81-312-6211-5.
  • 7.   Bresnahan GF, Roberts R, Shell WE, Ross J, Sobel BE. Deleterious effects due to hemorrhage after myocardial reperfusion. Am J Cardiol. 1974;33(1):82–6.
  • 8.   Lang TW, Corday E, Gold H, Meerbaum S, Rubins S, Costantini C, et al. Consequences of reperfusion after coronary occlusion. Effects on hemodynamic and regional myocardial metabolic function. Am J Cardiol. 1974;33(1):69–81.
  • 9.   Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977;56(5):786–94.
  • 10.   Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, GarciaDorado D, Hausenloy DJ, et al. Postconditioning and protection from reperfusion injury: Where do we stand: Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010;87(3):406–23.
  • 11.   Sreeniwas Kumar A, Sinha N. Cardiovascular disease in India: A 360 degree overview. Vol. 76, Medical Journal Armed Forces India. 2020. p. 1–3.
  • 12.   Helmuth RA, Wills ER, Aust C, Orr C. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined typ. J Am Coll Cardiol. 1987;9(4):785–801.
  • 13.   Fujiwara H, Onodera T, Tanaka M, Wu DJ, Kawai C, Hamashima Y. A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase. Circulation. 1986;73(4):749–57.
  • 14.   Lie JT, Lawrie GM, Morris GC, Winters WL. Hemorrhagic myocardial infarction associated with aortocoronary bypass revascularization. Am Heart J. 1978 Sep 1;96(3):295–302.
  • 15.   Oka S, Nakamura J, Kai T, Hoshino K, Watanabe K, Abe M, et al. An autopsy case report of extensive intramyocardial hemorrhage complicated with acute myocardial infarction. J Cardiol Cases [Internet]. 2020;22(3):121–4. Available from: https://doi.org/10.1016/j.jccase.2020.05.021.
  • 16.   Ochiai K, Shimada T, Murakami Y, Ishibashi Y, Sano K, Kitamura J, et al. Hemorrhagic Myocardial Infarction after Coronary Reperfusion Detected in Vivo by Magnetic Resonance Imaging in Humans: Prevalence and Clinical Implications. J Cardiovasc Magn Reson. 1999;1(3):247–56.
  • 17.   Hawranek M, Wróbel M, Nożyński J, Pres D, Gierlotka M, Trzeciak P, et al. Hemorrhagic Myocardial Infarction: Mortality Compared With STEMI Patients Treated With Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016;68(4):426–7.

Data Sharing Statement

There are no additional data available

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval

Acknowledgements

Information Not Provided

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Gokul G, Raoof MP, Yadav A, Gupta SK, Chandran VA, Abilash S. Reperfusion induced fatal hemorrhagic myocardial infarction: a case report. J Forensic Chem Toxicol. 2023;9(1):53–57.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


Received Accepted Published
October 11, 2022 November 13, 2022 June 30, 2023

DOI: http://dx.doi.org/10.21088/jfct.2454.9363.9123.4

Keywords

Occlusive coronary artery diseaseReperfusion therapyHemorrhagic Myocardial infarctionsudden death

Article Level Metrics

Last Updated

Monday 22 June 2026, 07:44:56 (IST)


732

Accesses

3
85
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received October 11, 2022
Accepted November 13, 2022
Published June 30, 2023

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator


Access this article



Share